News | Radiation Therapy | August 11, 2015

ASTRO Applauds U.S. Senators for Opposing Medicare’s Proposed Radiation Oncology Cuts

Cuts for 2016 would reduce physician payments to radiation oncology 5-7 percent or possibly more for community-based centers

ASTRO, Richard Burr, Debbie Stabenow, Medicare, proposed cuts, radiation oncology, MPFS, 2016

August 11, 2015 — The American Society for Radiation Oncology (ASTRO) released a statement applauding U.S. Sens. Richard Burr (R-N.C.) and Debbie Stabenow (D-Mich.) for their efforts to stop proposed Medicare payment cuts to radiation oncology cancer care.

Sens. Burr and Stabenow are asking their Senate colleagues for bipartisan support to tell the Centers for Medicare and Medicaid Services (CMS) to reconsider their proposed cuts to radiation oncology in the recently issued Medicare Physician Fee Schedule (MPFS) for 2016.

The proposed 2016 MPFS recommends reducing physician payments to radiation oncology, including cuts of about 5-7 percent to community-based cancer clinics—potentially higher for some centers depending on their patient populations. In their letter, the two Senators expressed “serious concern” that these cuts will have a significant impact on community-based centers and those that serve patients in rural areas, especially given that these same centers had payment reductions totaling nearly 20 percent during the last six years.

ASTRO will submit comments and recommendations in a letter to CMS by Sept. 8, 2015. 

The most significant portion of the cuts is due to an abrupt change in several policies, including setting values for newly created and revised radiation treatment delivery codes; increasing the assumed equipment utilization rate for linear accelerators used in cancer treatment; and removing the costs associated with several essential direct practice expense inputs, most notably on-board imaging, which ensures safe and accurate radiation treatments.

For more information: www.astro.org

Related Content

IBA Releases Razor Nano Ionization Chamber
News | Proton Therapy | September 22, 2017
September 22, 2017 — IBA (Ion Beam Applications S.A.) announced the release of the Razor Nano Chamber, the smallest a
Penn Medicine Treats World's First Patient on Varian's Halcyon System
News | Radiation Therapy | September 22, 2017
September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became
BrainLAB Announces FDA Clearance For Two New Indication-Specific Radiosurgery Software Applications
Technology | Treatment Planning | September 21, 2017
Brainlab announced that it has received U.S. Food and Drug Administration (FDA) clearance for Elements Spine SRS and...
Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017
News | Radiation Therapy | September 21, 2017
Accuray Inc. announced that data and first-hand experience with its advanced CyberKnife and Radixact Systems will be...
RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients
News | Proton Therapy | September 20, 2017
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first...
Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Overlay Init